The present study demonstrated that significantly reduced or increased activities of the NF-κB signaling pathway was found in ccRCC cells following treatment with ROS scavenger or stimulator, respectively (Fig. 1), which was consistent with the changes in pSTAT3 signaling activity and G6PD expression. This evidence concerns the gene G6PD and nonpapillary renal cell carcinoma.